Trial II

  • CMF + prednisone combined with or without oophorectomy for pre/perimenopausal patients with breast cancer and 4 or more positive nodes.

  • Study Chair
    Prof. Aron Goldhirsch - Milano, Italy

    Statistician
    Karen Price

    Director of the Data Management Center
    Holly Shaw

    IBCSG Data Management Center/FSTRF
    4033 Maple Road
    Amherst, New York 14226 USA
    Phone: +1 716 834 0900
    Fax: +1 716 833 3990
    Email: ibcsgI-IV@frontierscience.org

    Date of Activation
    July 1, 1978

    Date of Closure
    September 1, 1981

    Final Accrual
    1713 patients (1601 evaluable patients)

    Date of Discontinued Follow-up
    January 31, 2008

ETOP IBCSG Partners Foundation
Effingerstrasse 33
3008 Bern, Switzerland

Contact
Phone: +41 31 511 94 00
E-mail: contact@etop.ibcsg.org

Member Login